 Connection
Lisa Maier to Biomarkers
This is a "connection" page, showing publications Lisa Maier has written about Biomarkers.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.695 |
|
|
|
-
Yang IV, Konigsberg I, MacPhail K, Li L, Davidson EJ, Mroz PM, Hamzeh N, Gillespie M, Silveira LJ, Fingerlin TE, Maier LA. DNA Methylation Changes in Lung Immune Cells Are Associated with Granulomatous Lung Disease. Am J Respir Cell Mol Biol. 2019 01; 60(1):96-105.
Score: 0.323
-
Crouser ED, Fingerlin TE, Yang IV, Maier LA, Nana-Sinkam P, Collman RG, Kaminski N. Application of "Omics" and Systems Biology to Sarcoidosis Research. Ann Am Thorac Soc. 2017 Dec; 14(Supplement_6):S445-S451.
Score: 0.075
-
Fireman E, Lerman Y, Stark M, Pardo A, Schwarz Y, Van Dyke MV, Elliot J, Barkes B, Newman L, Maier L. A novel alternative to environmental monitoring to detect workers at risk for beryllium exposure-related health effects. J Occup Environ Hyg. 2014; 11(12):809-18.
Score: 0.057
-
Martin AK, Mack DG, Falta MT, Mroz MM, Newman LS, Maier LA, Fontenot AP. Beryllium-specific CD4+ T cells in blood as a biomarker of disease progression. J Allergy Clin Immunol. 2011 Nov; 128(5):1100-6.e1-5.
Score: 0.049
-
Tooker BC, Bowler RP, Orcutt JM, Maier LA, Christensen HM, Newman LS. SELDI-TOF derived serum biomarkers failed to differentiate between patients with beryllium sensitisation and patients with chronic beryllium disease. Occup Environ Med. 2011 Oct; 68(10):759-64.
Score: 0.047
-
Maier LA, Kittle LA, Mroz MM, Newman LS. Beryllium-stimulated neopterin as a diagnostic adjunct in chronic beryllium disease. Am J Ind Med. 2003 Jun; 43(6):592-601.
Score: 0.027
-
Serban KA, Pratte KA, Strange C, Sandhaus RA, Turner AM, Beiko T, Spittle DA, Maier L, Hamzeh N, Silverman EK, Hobbs BD, Hersh CP, DeMeo DL, Cho MH, Bowler RP. Unique and shared systemic biomarkers for emphysema in Alpha-1 Antitrypsin deficiency and chronic obstructive pulmonary disease. EBioMedicine. 2022 Oct; 84:104262.
Score: 0.026
-
Adduri RSR, Vasireddy R, Mroz MM, Bhakta A, Li Y, Chen Z, Miller JW, Velasco-Alzate KY, Gopalakrishnan V, Maier LA, Li L, Konduru NV. Realistic biomarkers from plasma extracellular vesicles for detection of beryllium exposure. Int Arch Occup Environ Health. 2022 10; 95(8):1785-1796.
Score: 0.025
-
Lin NW, Maier LA, Mroz MM, Jacobson S, MacPhail K, Liu S, Lei Z, Barkes BQ, Fingerlin TE, Hamzeh N, Mayer AS, Restrepo CI, Chhabra D, Yang IV, Li L. Genomic biomarkers in chronic beryllium disease and sarcoidosis. Respir Med. 2021 10; 187:106390.
Score: 0.024
-
Ryan SM, Fingerlin TE, Mroz M, Barkes B, Hamzeh N, Maier LA, Carlson NE. Radiomic measures from chest high-resolution computed tomography associated with lung function in sarcoidosis. Eur Respir J. 2019 08; 54(2).
Score: 0.021
-
Moller DR, Koth LL, Maier LA, Morris A, Drake W, Rossman M, Leader JK, Collman RG, Hamzeh N, Sweiss NJ, Zhang Y, O'Neal S, Senior RM, Becich M, Hochheiser HS, Kaminski N, Wisniewski SR, Gibson KF. Rationale and Design of the Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis (GRADS) Study. Sarcoidosis Protocol. Ann Am Thorac Soc. 2015 Oct; 12(10):1561-71.
Score: 0.016
-
Farris GM, Newman LS, Frome EL, Shou Y, Barker E, Habbersett RC, Maier L, Smith HN, Marrone BL. Detection of beryllium sensitivity using a flow cytometric lymphocyte proliferation test: the Immuno-Be-LPT. Toxicology. 2000 Feb 21; 143(2):125-40.
Score: 0.005
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|